Study ID
CTR ID
Official scientific title of the study
Condition
Progress
Publication
of Results
Protocol
Funding Souce
JMTO LC 12-01
UMIN
000007765
A randomized phase II trial of docetaxel or pemetrexed with or without gefitinib in elderly advanced non-small cell lung cancer patients harboring activating EGFR mutation after failure of the therapy as
first-line treatment.
Non-small cell lung cancer
Open public recruiting
Unpublised
Astra Zeneca
JMTO LC 09-01
UMIN
000001826
Randomized phase III trial of Docetaxel versus docetaxel plus S-1 for second-line treatment of non-small cell lung cancer (NSCLC)
Non-small cell lung cancer
No longer recruiting
Unpublised
JMTO LC 08-01
UMIN
000001246
Randomized phase II trial comparing amrubicine/irinotecan with cisplatin/irinotecan in patients with extensive-stage small-cell lung cancer: (JMTO LC 08-01)
Small cell lung cancer
No longer recruiting
Unpublised
JMTO PCa10-01
UMIN
000004096
A study to evaluate efficacy and safety of docetaxel combined with dexamethasone in patients with hormone refractory prostate cancer ; JMTO PCa10-01
Prostate cancer
No longer recruiting
Unpublised
JMTO PREV 07-01
UMIN
000000776
NCT
00508690
Randomized controlled trial of antibiotic prophylaxis in elective laparoscopic colorectal surgery: Oral and systemic versus systemic antibiotics
Colorectal tumor with planned elective laparoscopic resection
No longer recruiting
Unpublised
ver150109
Study ID
CTR ID
Official scientific title of the study
Condition
Progress
Publication
of Results
Protocol
Funding Souce
JMTO BC 08-01
UMIN
000001217
Efficacy of goserelin plus anastrozole in premenopausal women with advanced or
recurrent breast cancer refractory to an LH-RH analogue with tamoxifen: Results
of the JMTO BC08-01 phase¶trial.
Breast cancer
Completed
Publised
Oncology Reports
2013;29:1707-1713
JMTO LC 07-02
UMIN
000001280
A feasibility study of endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) in evaluation of mediastinal nodal metastasis of lung cancer
Lung cancer
No longer recruiting
Unpublised
JMTO LC 07-01
UMIN
000001225
Carboplatin plus either docetaxel or paclitaxel for Japanese patients with advanced
non-small cell lung cancer.
Non-small cell lung cancer
Completed
Publised
Anticancer Research 2013 ; 33 : 4631-4637
JMTO LC 05-01
UMIN
000001271
Prognostic factors after complete resection of pN2 non-small cell lung cancer.
Non-small cell lung cancer
Completed
Publised
Journal of Thoracic and Cardiovascular Surgery 2013; 146 : 788-795
JMTO LC 03-03
A phase I study of amrubicin (AMR) and fixed-dose of irinotecan (CPT-11) in
relapsed small cell lung cancer (SCLC) -Japan Multinational Trial Organization
(JMTO) LC0303.
relapsed small cell lung cancer (SCLC)
Completed
Publised
Journal of Thoracic Oncology¡¡2012;7:1845-1849
Study ID
CTR ID
Official scientific title of the study
Condition
Progress
Publication
of Results
Protocol
Funding Souce
JMTO LC 03-02
Interstitial lung disease in gefitinib treated Japanese patients with non-small cell
lung cancer ¡Ýa retrospective analysis : JMTO LC03-02.
Non-small cell lung cancer
Completed
Publised
BMC Research Notes 2009;2:157
JMTO LC 02-02
A Weekly combination of carboplatin and irinotecan for previously untreated
extensive disease small cell lung cancer, results of minimum follow-up of 3 years :
A multi-center phase II trial JMTO LC02-02.
Small cell lung cancer
Completed
Publised
Japanese Journal of Clinical Oncology¡¡2012;42:387-393
JMTO BC 02-01
Efficacy of doxifluridine combined with weekly paclitaxel therapy in the treatment
of advanced or recurrent breast cancer: results of the JMTO BC01 phase II trial.
Breast cancer
Completed
Publised
Anti-Cancer Drugs 2008;19:911-915
JMTO LC 00-04
Non-Small Cell Lung Cancer: A Model for Assessing Population-Related
Pharmacogenomics.
Journal of Clinical Oncology 2009;21:3540-3546
Serum osteopontin levels are highly prognostic for survival in advanced
non-small-cell lung cancer: results from JMTO-LC0004.
Journal of Thoracic Oncology 2009;4:1104-1110
Non-small cell lung cancer
Completed
Publised
Journal of Clinical Oncology 2009;21:3540-3546
Journal of Thoracic Oncology 2009;4:1104-1110
JMTO LC 00-03
Vinorelbine plus gemcitabine followed by docetaxel versus carboplatin plus
paclitaxel in patients with advanced non-small-cell lung cancer: a randomised,
open-label, phase· study.
Lancet Oncology 2008;9:1135-42
Non-small cell lung cancer
Completed
Publised
Lancet Oncology 2008;9:1135-1142
European Journal of Cancer 2009;45:1950-1958.
British Journal of Cancer 2009;101:1537-1542.
Study ID
CTR ID
Official scientific title of the study
Condition
Progress
Publication
of Results
Protocol
Funding Souce
JMTO LC 00-02
Gemcitabine and vinorelbine followed by docetaxel in patients with advanced
non-small-cell lung cancer : a multi-institutional phase ¶ trial of nonplatinum
sequential triplet combination chemotherapy (JMTO LC00-02).
Non-small cell lung cancer
Completed
Publised
British Journal of Cancer 2003;88:342-347
JMTO LC 00-01
A feasibility study of paclitaxel 225 mg/m2 and carboplatin AUC = 6 in untreated
advanced non-small cell lung cancer patients in Japan.
Non-small cell lung cancer
Completed
Publised
Japanese Journal of Clinical Oncology 2002;32:48-53
JMTO OC 01-01
The impact of therapeutic modalities on the outcome of advanced epithelial ovarian
cancer patients treated in Japan. A JMTO study.
J Clin Oncol 22:473s,2004.
A new prognostic index of advanced epithelial ovarian cancer (PIEPOC): A JMTO
OC01-01 study.
Proc ASCO 2006 (abstract #5061)
Ovarian cancer
Completed
Publised
J Clin Oncol 22:473s,2004.
Proc ASCO 2006 (abstract #5061)
¡¡Top
¡¡
¡¡
¡¡
Operations Office
¢©460-0002
P-A Bldg. 3F,
2-14-10 Marunouchi,
Naka-ku, Nagoya,
Aichi, Japan
¡¡
Phone
+81-52-218-3301
Facsimile
+81-52-265-9523